Xiaotong Yao
Overview
Explore the profile of Xiaotong Yao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang W, Wang W, Zhao S, Yuan H, Zhang Y, Yao X, et al.
Sensors (Basel)
. 2024 Dec;
24(23).
PMID: 39686058
The strong wind environment causes the additional conductor of the overhead contact system (OCS) of the Lanzhou-Xinjiang high-speed railway to gallop, significantly impacting the safe operation of the train. This...
2.
Liu J, Zhou Y, Lyu Q, Yao X, Wang W
Exploration (Beijing)
. 2024 Jun;
4(3):20230025.
PMID: 38939867
Protein-based drugs have shown unique advantages to treat various diseases in recent years. However, most protein therapeutics in clinical use are limited to extracellular targets with low delivery efficiency. To...
3.
4.
Choo Z, Behr J, Deshpande A, Hadi K, Yao X, Tian H, et al.
Nat Genet
. 2023 Nov;
55(12):2139-2148.
PMID: 37945902
Short-read sequencing is the workhorse of cancer genomics yet is thought to miss many structural variants (SVs), particularly large chromosomal alterations. To characterize missing SVs in short-read whole genomes, we...
5.
Setton J, Hadi K, Choo Z, Kuchin K, Tian H, Da Cruz Paula A, et al.
Nature
. 2023 Aug;
621(7977):129-137.
PMID: 37587346
Homologous recombination (HR) deficiency is associated with DNA rearrangements and cytogenetic aberrations. Paradoxically, the types of DNA rearrangements that are specifically associated with HR-deficient cancers only minimally affect chromosomal structure....
6.
Gerstung M, Jolly C, Leshchiner I, Dentro S, Gonzalez S, Rosebrock D, et al.
Nature
. 2023 Jan;
614(7948):E42.
PMID: 36697833
No abstract available.
7.
Rheinbay E, Nielsen M, Abascal F, Wala J, Shapira O, Tiao G, et al.
Nature
. 2023 Jan;
614(7948):E40.
PMID: 36697832
No abstract available.
8.
Paulson T, Galipeau P, Oman K, Sanchez C, Kuhner M, Smith L, et al.
Nat Commun
. 2022 Apr;
13(1):2300.
PMID: 35484108
While the genomes of normal tissues undergo dynamic changes over time, little is understood about the temporal-spatial dynamics of genomes in premalignant tissues that progress to cancer compared to those...
9.
Choi J, Manzano A, Dong W, Bellone S, Bonazzoli E, Zammataro L, et al.
Proc Natl Acad Sci U S A
. 2021 Apr;
118(15).
PMID: 33876771
Uterine leiomyosarcomas (uLMS) are aggressive tumors arising from the smooth muscle layer of the uterus. We analyzed 83 uLMS sample genetics, including 56 from Yale and 27 from The Cancer...
10.
Dentro S, Leshchiner I, Haase K, Tarabichi M, Wintersinger J, Deshwar A, et al.
Cell
. 2021 Apr;
184(8):2239-2254.e39.
PMID: 33831375
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important clinical challenge. However, the extent, origin, and drivers of ITH across cancer types are poorly understood. To...